People have been asking what Oncotarget is, and the answer is quite simple. As the name implies, Oncotarget ‘targets’ oncology — the study and treatment of cancer. Oncotarget is a journal, an online semiweekly journal devoted to the study and treatment of cancer. The journal sometimes publishes articles on other research that might be of value to the medical and oncology fields. Check the journal at SCImago Journal & Country Rank.
Oncology is the study of cancer and its treatment. Since Oncotarget ‘targets’ cancer, it is no surprise that in July of 2017, Oncotarget published an article by a number of Chinese researchers on the subject of thyroid cancer. The research material was made available to doctors and researchers all over the world who were interested in treating thyroid cancer, simply by reading and investigating the material published in Oncotarget. This had a major impact on the medical field, as the treatment described by the researchers in the journal was successfully used and completed by doctors elsewhere. The results proved and solidified the results of using Oncotarget for everyday use and research. Download output styles at Endnote.com
Oncotarget publishes other detailed medical research from a variety of sources, and much of its publication data relates to the cancer research being done by its contributors.
Doctors Mikhail Blagosklonny and Andrei V. Gudkov are the editors in chief of the semiweekly journal. Dr. Blagosklonny received his degree in medicine in Russia. Dr. Gudkov is associated with the Roswell Park Cancer Institute.
Oncotarget has been of great service to researchers, doctors, and patients over the past few years. We look forward to much more from this semiweekly journal of medical research.